X4 Pharmaceuticals (XFOR) Inventory Average (2024 - 2025)
X4 Pharmaceuticals (XFOR) posted Inventory Average of $4.3 million for Q4 2025, up 18.06% on a QoQ basis from $3.6 million in Q3 2025, and up 62.66% year-over-year from $2.6 million in Q4 2024.
X4 Pharmaceuticals (XFOR) Inventory Average (2024 - 2025) Analysis & Trends
X4 Pharmaceuticals' Inventory Average history runs 2 years deep, the most recent figure standing at $4.3 million for Q4 2025.
- Quarterly Inventory Average rose 62.66% year-over-year to $4.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.3 million (up 62.66% YoY) and the FY2025 annual result came in at $3.6 million, changed N/A from the prior year.
- Inventory Average was $4.3 million for Q4 2025 at X4 Pharmaceuticals, up from $3.6 million in the prior quarter.
- Across five years, Inventory Average topped out at $4.3 million in Q4 2025 and bottomed at $1.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 644.91 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn | 4.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | 3.13 Mn |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 1.64 Mn |